or Try an Advanced Search...

    Biotie Therapies Stocks List

    Symbol Grade Name % Change
    CANF D Can-Fite Biopharma Ltd Sponsored ADR (Israel) 0.47
    VTVT D vTv Therapeutics Inc. 2.29
    LXRX D Lexicon Pharmaceuticals, Inc. -37.44
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Diabetes Glaucoma Inflammatory Diseases Medicine Psoriasis Rheumatoid Arthritis Alzheimer's Disease Arthritis Autoimmune Disease Biotechnology Buparlisib Cancer Carcinoma Chronic Obstructive Pulmonary Disease Clinical Development Clinical Trial Colitis Disease Drug Discovery

    Related ETFs - A few ETFs which own one or more of the above listed Biotie Therapies stocks.

    Symbol Grade Name Weight
    BBP A BioShares Biotechnology Products Fund 1.49
    QQQS A Invesco NASDAQ Future Gen 200 ETF 0.53
    TXSS D Texas Small Cap Equity Index ETF 0.08
    IBBQ D Invesco Nasdaq Biotechnology ETF 0.07
    GINN A Goldman Sachs Innovate Equity ETF 0.06
    View all Biotie Therapies ETFs...
    Compare ETFs
    Compare BBP to GINN Compare QQQS to IBBQ Compare TXSS to GINN

        Biotie Therapies Stocks Recent News

        Date Stock Title
        Nov 1 LXRX Sector Update: Health Care Stocks Rise Late Afternoon
        Nov 1 LXRX Top Midday Decliners
        Nov 1 LXRX Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
        Oct 31 LXRX Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
        Oct 31 LXRX Lexicon's sotagliflozin fails to win support of FDA AdComm for diabetes (update)
        Oct 27 LXRX FDA Endocrinologic and Metabolic Drugs Advisory Committee to hold a meeting
        Oct 26 VTVT vTv Therapeutics Faces License Agreement Termination
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Diabetes Glaucoma Inflammatory Diseases Medicine Psoriasis Rheumatoid Arthritis Alzheimer's Disease Arthritis Autoimmune Disease Biotechnology Buparlisib Cancer Carcinoma Chronic Obstructive Pulmonary Disease Clinical Development Clinical Trial Colitis Disease Drug Discovery
        Biotie Therapies

        Biotie Therapies was a Finnish biotechnology and pharmaceutics company that was acquired by Acorda Therapeutics in January 2016. The company's research and development was focused on drugs for neurodegenerative and psychiatric disorders like Parkinson's disease, Alzheimer's disease and other cognitive disorders, alcohol and drug dependence and post traumatic stress disorder, and inflammatory and fibrotic liver disease. The company's headquarters is in Turku, Western Finland, and it is listed on NASDAQ OMX Helsinki.

        More about Biotie Therapies
        Browse All Tags